You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endothelin B Receptors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19

Terminated
Has Results
  • Lymphoma, B-Cell
  • +3 more
  • Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2022

MDD Trial in London (MIJ821)

Not yet recruiting
  • Major Depressive Disorder
  • London, United Kingdom
    Parexel Early Phase Clinical Unit (LONDON)
Dec 18, 2022

Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)

Recruiting
  • Glioblastoma Multiforme
  • CAR.B7-H3T cells infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 25, 2022

Acute Ischemic Stroke, Cerebral Stroke Trial (Drug: Normal Saline, Sovateltide)

Not yet recruiting
  • Acute Ischemic Stroke
  • Cerebral Stroke
  • (no location specified)
Jan 11, 2023

COVID Trial (Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid)

Not yet recruiting
  • COVID
  • Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid
  • (no location specified)
Jun 5, 2021

Acute Asthma Responsiveness and B2 Adrenergic Receptors

Completed
  • Acute Asthma
    • Cleveland, Ohio
      MetroHealth Medical Center
    Aug 26, 2021

    Tobacco Use Disorder, Tobacco Smoking Trial in Baltimore ([F18]-ASEM

    Recruiting
    • Tobacco Use Disorder
    • Tobacco Smoking
    • [F18]-ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-[18F]fluorodibenzo[b,d]thiophene 5,5-dioxide)
    • Contingency Management
    • Baltimore, Maryland
      Johns Hopkins Behavioral Pharmacology Research Unit
    Jun 7, 2022

    COVID-19 Trial (Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2))

    Not yet recruiting
    • COVID-19
    • Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2)
    • (no location specified)
    Jun 5, 2021

    Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)

    Active, not recruiting
    • Non-Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • autologous or syngeneic PBTLs and EBV-CTLs
    • Houston, Texas
    • +1 more
    Feb 6, 2022

    Vasculitis Trial in Edinburgh (BQ123, BQ123/788, Placebo)

    Completed
    • Vasculitis
    • Edinburgh, Midlothian, United Kingdom
    • +1 more
    Nov 30, 2020

    Acute Cerebral Ischemia Trial in India (Sovateltide, Normal Saline)

    Recruiting
    • Acute Cerebral Ischemia
    • Guntur, Andhra Pradesh, India
    • +5 more
    Jul 18, 2023

    Leukemia, B-Cell Trial in Houston (Autologous TriCAR T-cells and lymphodepletion chemo)

    Not yet recruiting
    • Leukemia, B-Cell
    • Autologous TriCAR T-cells and lymphodepletion chemotherapy
    • Houston, Texas
    • +1 more
    Nov 3, 2021

    Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Embryonal Tumor Trial in Houston ((C7R)-GD2.CART cells, Cyclophosphamide,

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • +3 more
    • (C7R)-GD2.CART cells
    • +2 more
    • Houston, Texas
      Texas Children's Hospital
    Feb 7, 2022

    Alzheimer, Dementia Trial in India (Normal Saline along with standard treatment, PMZ-1620 (sovateltide) along with standard

    Completed
    • Alzheimer Disease
    • Dementia
    • Normal Saline along with standard treatment
    • PMZ-1620 (sovateltide) along with standard treatment
    • Chandigarh, India
    • +4 more
    Jan 11, 2023

    Cardiovascular Diseases, Cardiovascular Risk Factor, Vasoconstriction Trial in Arlington (BQ-788, BQ-123, L-Arginine)

    Recruiting
    • Cardiovascular Diseases
    • +2 more
    • Arlington, Texas
      Science and Engineering Research and Innovation Building
    Feb 7, 2022

    Cardiovascular Risk Factor Trial in Newark (No to Low Endogenous Estrogen, Estradiol)

    Recruiting
    • Cardiovascular Risk Factor
    • No to Low Endogenous Estrogen
    • Estradiol
    • Newark, Delaware
      University of Delaware
    Oct 14, 2021

    Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL Trial in Houston (CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T

    Recruiting
    • Non-Hodgkin's Lymphoma
    • +2 more
    • CD19.CAR-CD28Z T Cells - dose escalation 2
    • CD19.CAR-CD28Z T Cells - dose escalation 1
    • Houston, Texas
    • +1 more
    Feb 10, 2022

    Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

    Not yet recruiting
    • Prostate Carcinoma
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2023

    Angiotensin II and Angiotensin II Receptors in Septic Shock

    Completed
    • Shock, Septic
    • Drug Steroid
    • Malatya, Turkey
    • +1 more
    Feb 6, 2021

    ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases Trial in Edinburgh (Sparsentan)

    Recruiting
    • ANCA Associated Vasculitis
    • +2 more
    • Edinburgh, United Kingdom
      Centre for Cardiovascular Science, Queen's Medical Research Inst
    Jan 26, 2023

    Heart Failure Trial in Salt Lake City (BQ-123)

    Completed
    Has Results
    • Heart Failure
    • Salt Lake City, Utah
      VA Salt Lake City Health Care System, Salt Lake City, UT
    Dec 17, 2021

    Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, Neonatal Encephalopathy Trial in India (Normal Saline along with standard

    Not yet recruiting
    • Hypoxic-Ischemic Encephalopathy
    • +2 more
    • Normal Saline along with standard treatment
    • Sovateltide along with standard treatment
    • Belgaum, Karnataka, India
    • +3 more
    Aug 22, 2022

    Perimenopause, Vasodilation, Estrogen Trial in Newark (Estradiol (mylan or vivelle dot patch), Placebo)

    Recruiting
    • Perimenopause
    • +2 more
    • Estradiol (mylan or vivelle dot patch)
    • Placebo
    • Newark, Delaware
      University of Delaware
    Nov 2, 2022

    Hepatitis B Trial in Oxford (Hepatitis B vaccine)

    Completed
    • Hepatitis B
    • Hepatitis B vaccine
    • Oxford, Oxfordshire, United Kingdom
      Centre for Clinical Vaccinology & Tropical Medicine (CCVTM)
    Jan 13, 2021

    Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

    Not yet recruiting
    • Preterm Labor
      • (no location specified)
      May 9, 2023